Human Immunology News Volume 10.05 | Feb 8 2022

    0
    61






    2022-02-08 | HIN 10.05


    Human Immunology News by STEMCELL Technologies
    Vol. 10.07 – 8 February, 2022
    TOP STORY

    CRISPR Activation and Interference Screens Decode Stimulation Responses in Primary Human T Cells

    Scientists developed a CRISPR activation and CRISPR interference discovery platform in primary human T cells and performed genome-wide screens for functional regulators of cytokine production in response to stimulation.
    [Science]

    AbstractPress Release
    Register now for the 3rd IMMA meeitng.
    PUBLICATIONSRanked by the impact factor of the journal

    Molecular Signatures of Antitumor Neoantigen-Reactive T Cells from Metastatic Human Cancers

    By mapping 55 neoantigen-specific T cell receptor clonotypes from 10 metastatic human tumors to their single-cell transcriptomes, investigators identified signatures of CD8+ and CD4+ neoantigen-reactive tumor-infiltrating lymphocytes.
    [Science]

    AbstractPress Release

    CECR2 Drives Breast Cancer Metastasis by Promoting NF-κB Signaling and Macrophage-Mediated Immune Suppression

    Researchers found that distant metastases were more immune inert with increased M2 macrophages compared to their matched primary tumors.
    [Science Translational Medicine]

    Full ArticlePress Release

    Primary Tumor Associated Macrophages Activate Programs of Invasion and Dormancy in Disseminating Tumor Cells

    Investigators studied the live lung longitudinally and follow the fate of individual disseminated tumor cells that spontaneously disseminated from orthotopic breast tumors.
    [Nature Communications]

    Full Article

    PD-1 Blockade Therapy Promotes Infiltration of Tumor-Attacking Exhausted T Cell Clonotypes

    Using single-cell sequencing, scientists showed that tumor-induced lymphocytes include skewed T cell clonotypes, which were characterized by exhaustion or nonexhaustion signatures.
    [Cell Reports]

    Full ArticleGraphical Abstract

    Effect of Different Initial Rituximab Regimens on B Cell Depletion in Children with Autoimmune Neurological Diseases

    Researchers investigated the effect of different initial rituximab (RTX) regimens on B cell depletion. This single-center retrospective analysis included children with autoimmune neurological diseases who received RTX.
    [Multiple Sclerosis Journal]

    Abstract

    Lipoxins Modulate Neutrophil Oxidative Burst, Integrin Expression and Lymphatic Transmigration Differentially in Human Health and Atherosclerosis

    Scientists evaluated the effects of the specialized pro-resolving mediators lipids, lipoxin A4 and lipoxin B4, on neutrophils isolated from patients with atherosclerosis compared with healthy controls.
    [FASEB Journal]

    Full Article

    Impaired Neutrophil Extracellular Trap Formation in β-Thalassaemia/HbE

    The authors demonstrated abnormalities of neutrophil function, namely neutrophil extracellular trap formation in splenectomised and non-splenectomised β-thalassaemia/HbE patients who had iron overload.
    [Scientific Reports]

    Full Article

    Cytosolic dsRNA Improves Neonatal Innate Immune Responses to Adjuvants in Use in Pediatric Vaccines

    Researchers showed that myeloid cells from cord blood could be activated to express T cell costimulatory markers, and also to produced Th1 promoting cytokines.
    [Journal of Leukocyte Biology]

    Full Article

    The Effects of Sulfated Secondary Bile Acids on Intestinal Barrier Function and Immune Response in an Inflammatory In Vitro Human Intestinal Model

    Scientists investigated the effects of sulfated deoxycholic acid, sulfated lithocholic acid, and their unsulfated forms on intestinal barrier function and immune response..
    [Heliyon]

    Full Article
    Register now for the 4th Annual Neuroimmunology Drug Development Summit.
    REVIEWS

    Cell-Intrinsic View of the Aryl Hydrocarbon Receptor in Tumor Immunity

    Investigators describe the function of the aryl hydrocarbon receptor in different immune cells, and connect with their roles in cancer immunology.
    [Trends in Immunology]

    Abstract
    INDUSTRY AND POLICY NEWS

    SV Investment and Orange Grove Bio Establish Partnership to Jointly Source and Develop Novel Therapeutics in the US and Korea

    Orange Grove Bio and SV Investment announced the establishment of a new partnership through which the companies will collaborate on jointly sourcing and developing novel therapeutics in the United States and Korea.
    [Orange Grove Bio (Globe Newswire, Inc.)]

    Press Release

    Actuate Therapeutics Announces Initiation of a Multicenter Randomized Trial of Elraglusib plus FOLFIRINOX as First Line Therapy for Advanced Pancreatic Cancer

    Actuate Therapeutics, Inc. announced the opening of a randomized study of elraglusib plus FOLFIRINOX alone or with Losartan for patients with advanced pancreatic cancer in the first-line setting.
    [Actuate Therapeutics, Inc. (Globe Newswire, Inc.)]

    Press Release

    FEATURED EVENT

    EMBO: Stroke-Immunology

    March 9 – 12, 2022
    Munich, Germany

    > See All Events

    JOB OPPORTUNITIES

    Research Association – Myeloma Cancer Cells

    Imperial College London – London, England, United Kingdom

    Research Associate – Molecular Biologist

    King’s College London- London, England, United Kingdom

    Research Associate – B Cells in Cancer Immune Survelliance

    Imperial College London – London, England, United Kingdom

    Research Associate – Cell Immunotherapy for Blood Cancers

    Imperial College London – London, England, United Kingdom

    Research Associate – B Cells in Cancer Immune Survelliance

    Imperial College London – London, England, United Kingdom

    Postdoctoral Fellow – Cell Death in the Innate Immune System

    Ragon Institute – Boston, Massachusetts, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Human Immunology News Twitter